SHH · 601607.SS
Shanghai Pharmaceuticals Holding Co., Ltd
CN¥16.50+CN¥0.07 (+0.43%)
Shanghai Pharmaceuticals Holding Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 11.1% below the high.
Loading market information…
SHH · 600511.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:29 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
China National Medicines Corporation Ltd.’s quoted price sits in the lower half of its reported 52-week range, 10.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
China National Medicines Corporation Ltd.’s forward annual dividend is CN¥0.80 per share, paid annual. The forward yield is 2.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
China National Medicines Corporation Ltd.’s next earnings report is currently expected on Mar 25, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow China National Medicines Corporation Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 |
|---|
| Apr 24, 2025 |
| CN¥0.61 |
| CN¥12.71B |
| Q4 2024 | Mar 19, 2025 | CN¥0.69 | CN¥12.57B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥16.50+CN¥0.07 (+0.43%)
Shanghai Pharmaceuticals Holding Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 11.1% below the high.
CN¥26.18+CN¥0.98 (+3.89%)
Yifeng Pharmacy Chain Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.5% below the high.
CN¥5.22+CN¥0.07 (+1.36%)
Jointown Pharmaceutical Group Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 10.62% below the high.
CN¥9.74+CN¥0.19 (+1.99%)
Liaoning Cheng Da Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.48% below the high.
CN¥8.86-CN¥0.01 (-0.11%)
China Meheco Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.53% below the high.
CN¥21.04+CN¥0.10 (+0.48%)
China National Accord Medicines Corporation Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.64% below the high.
CN¥9.98+CN¥0.22 (+2.25%)
Zhejiang Int'l Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.5% below the high.
CN¥22.60-CN¥0.23 (-1.01%)
Shanghai General Healthy Information and Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.22% below the high.
